Find Information About:

Drugs & Supplements

Get information and reviews on prescription drugs, over-the-counter medications, vitamins, and supplements. Search by name or medical condition.

Pill Identifier

Pill Identifier

Having trouble identifying your pills?

Enter the shape, color, or imprint of your prescription or OTC drug. Our pill identification tool will display pictures that you can compare to your pill.

Get Started

My Medicine

Save your medicine, check interactions, sign up for FDA alerts, create family profiles and more.

Get Started

WebMD Health Experts and Community

Talk to health experts and other people like you in WebMD's Communities. It's a safe forum where you can create or participate in support groups and discussions about health topics that interest you.

  • Second Opinion

    Second Opinion

    Read expert perspectives on popular health topics.

  • Community


    Connect with people like you, and get expert guidance on living a healthy life.

Got a health question? Get answers provided by leading organizations, doctors, and experts.

Get Answers

Sign up to receive WebMD's award-winning content delivered to your inbox.

Sign Up

Pain Management Health Center

Font Size

FDA Panel: No Heart-Safety Advantage With Naproxen

Some studies had suggested naproxen (Aleve) might pose less of a threat than other painkillers

WebMD News from HealthDay

By HealthDay staff

HealthDay Reporter

TUESDAY, Feb. 10, 2014 (HealthDay News) -- The science isn't convincing enough to say that naproxen -- the key pain reliever in Aleve -- is safer for the heart than other popular anti-inflammatory drugs such as ibuprofen (Advil and Motrin), U.S. health advisers ruled Tuesday.

The decision was highly anticipated, since a vote in favor of naproxen's superiority might have led to a product labeling change, experts said.

However, the 16-9 vote by the advisory panel to the U.S. Food and Drug Administration did not find enough evidence to put naproxen ahead of other pain relievers in terms of heart risk. The FDA isn't required to follow the recommendations of its advisory committees but it usually does so.

Naproxen, ibuprofen and aspirin fall under the umbrella term nonsteroidal anti-inflammatory drugs (NSAIDs). Millions of people take these medicines to help relieve muscle aches, headaches and pain from arthritis and injuries. These medicines also include the prescription drug Celebrex.

Since 2005, labeling laws have required a heart warning on these anti-inflammatory drugs. That warning stemmed from Merck's withdrawal of the NSAID Vioxx from the market in 2004 because of a notable increased risk of heart attack among Vioxx users.

An FDA panel concluded earlier this month that naproxen didn't seem to carry the same heart risks as the other NSAIDs. That decision was based on a safety review involving 350,000 people using different pain relievers.

But the FDA advisory committee decided Tuesday, after two days of hearings, that there wasn't enough evidence to state that naproxen was safer for the heart.

"If I were forced to bet on what the truth is, my bet would be that naproxen is somewhat safer," panelist Dr. Susan Ellenberg, of the University of Pennsylvania, told the Associated Press. "On the other hand, I'm not sure how that relates to our regulatory standard, as there's still a lot of uncertainty here."

But another panelist, Dr. Peter Kaboli of the University of Iowa, told the AP: "I'm convinced enough to change my own use of NSAIDs to naproxen, and that of my patients, based on what I've heard these last two days."

Aspirin wasn't a focus of this week's hearings.

Today on WebMD

pain in brain and nerves
Top causes and how to find relief.
knee exercise
8 exercises for less knee pain.
acupuncture needles in woman's back
How it helps arthritis, migraines, and dental pain.
chronic pain
Get personalized tips to reduce discomfort.
illustration of nerves in hand
lumbar spine
Woman opening window
Man holding handful of pills
Woman shopping for vegetables
Sore feet with high heel shoes
acupuncture needles in woman's back
man with a migraine